Edwards Lifesciences falls short

Edwards Lifesciences Corp. (NYSE: EW) disappointed with third quarter revenue that fell short of expectations. The stock price plummeted $19.43 to close at $94.25.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.